Downregulation of GEP100 Improved the Growth Inhibition Effect of Erlotinib Through Modulating Mesenchymal Epithelial Transition Process in Pancreatic Cancer

Pancreas
Chuan-Gao XieJian-Ting Cai

Abstract

The epidermal growth factor receptor is overexpressed in the majority of pancreatic cancer. Epidermal growth factor receptor tyrosine kinase inhibitor erlotinib was approved to treat patients combining with gemcitabine. However, the sensitivity is low. Here, we try to reveal the regulatory role of guanine nucleotide exchange protein 100 (GEP100) in erlotinib sensitivity. We investigated the correlation between GEP100 expression and sensitivity to erlotinib in different pancreatic cancer cell lines, followed by examination of the effect of GEP100 on erlotinib sensitivity by establishing the stable knocked-down cell line. The expression level of epithelial mesenchymal transition-related protein was examined by Western blot, and the regulatory mechanism was investigated by short hairpin RNA. Xenograft experiment was also performed in nude mice. We identified a significant correlation between sensitivity to erlotinib and expression of GEP100. GEP100 downregulation increased its sensitivity to erlotinib. E-cadherin short hairpin RNA treatment inhibited this sensitivity. Immunohistochemical staining showed a mutual exclusive expression pattern of GEP100 and E-cadherin in human pancreatic cancer tissues. Xenograft showed that downregu...Continue Reading

References

Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·A SomeyaM Vaughan
Mar 31, 2004·Lancet·Donghui LiJames L Abbruzzese
Jun 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Toyoko HiroiMartha Vaughan
Mar 25, 2008·Therapeutics and Clinical Risk Management·Naureen StarlingDavid Cunningham
Dec 6, 2008·Traffic·Emmanuella Delva, Andrew P Kowalczyk
Apr 22, 2009·Biochemical and Biophysical Research Communications·Somesh Baranwal, Suresh K Alahari
Mar 4, 2010·The AAPS Journal·Jing LiJessie L-S Au
Jun 17, 2010·Nature Reviews. Clinical Oncology·Deric L WheelerPaul M Harari
Mar 31, 2012·Current Drug Targets·T TroianiF Ciardiello
Oct 24, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lauren Averett ByersJohn V Heymach
Sep 11, 2014·The New England Journal of Medicine·David P RyanNabeel Bardeesy
Nov 28, 2014·Current Drug Targets·Reza NedaeiniaMajid Ghayour-Mobarhan
Jul 12, 2016·Biochemical and Biophysical Research Communications·Ichwaku RastogiNeelu Puri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.